Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Invested Capital (2022 - 2025)

bioAffinity Technologies has reported Return on Invested Capital over the past 4 years, most recently at 0.01% for Q4 2025.

  • Quarterly Return on Invested Capital rose 1.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.02% for FY2025, 0.0% changed from the prior year.
  • Return on Invested Capital was 0.01% for Q4 2025 at bioAffinity Technologies, up from 0.03% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q4 2022 and troughed at 0.89% in Q2 2025.
  • The 4-year median for Return on Invested Capital is 0.01% (2024), against an average of 0.08%.
  • The largest YoY upside for Return on Invested Capital was 1bps in 2025 against a maximum downside of -88bps in 2025.
  • A 4-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then plummeted by -363bps to 0.01% in 2023, then plummeted by -115bps to 0.02% in 2024, then surged by 48bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Return on Invested Capital are 0.01% (Q4 2025), 0.03% (Q3 2025), and 0.89% (Q2 2025).